| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6095642 | Gastroenterology | 2011 | 12 Pages |
Abstract
IL-5 is involved in the pathogenesis of EoE in children. Mepolizumab, an antibody against IL-5, reduces esophageal eosinophilic inflammation in these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Amal H. Assa'ad, Sandeep K. Gupta, Margaret H. Collins, Mike Thomson, Amy T. Heath, Deborah A. Smith, Teresa L. Perschy, Cynthia H. Jurgensen, Hector G. Ortega, Seema S. Aceves,